Kotak Reiterates Reduce (3) Rating on Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (RDY) May 13, 2026 12:47AM
Goldman Sachs Downgrades Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) to Sell Apr 23, 2026 02:12PM
FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product' Mar 9, 2026 10:53AM
FDA accepts Dr. Reddy's biosimilar abatacept application for review Feb 20, 2026 10:57AM
Dr. Reddys Labs (RDY) Reports Q4 EPS of Rs14.52 Jan 22, 2026 02:37AM


Oct 30, 2025 01:09AM Goldman Sachs Reiterates Neutral Rating on Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY)
Jul 24, 2025 01:05AM Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR1,100 at Jefferies
Jul 24, 2025 01:03AM Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR1,200 at Goldman Sachs
Jul 23, 2025 09:58AM Dr. Reddys Labs (RDY) Misses Q2 EPS by 1c
Jul 14, 2025 12:52AM Morgan Stanley Starts Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY) at Equalweight
Jul 8, 2025 05:35AM Macquarie Downgrades Dr. Reddy's Laboratories (DRRD:IN) (RDY) to Neutral
Jun 5, 2025 08:58AM Dr. Reddy's (RDY) stock rises on biosimilar collaboration with Alvotech (ALVO)
Jun 4, 2025 11:51PM HSBC Upgrades Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) to Buy
May 12, 2025 03:01AM Dr. Reddys Labs (RDY) Tops Q1 EPS by 1c
May 12, 2025 01:08AM Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) PT Lowered to INR1,060 at JPMorgan
Mar 27, 2025 11:49AM Bio-Thera and Dr. Reddy's (RDY) Execute Exclusive Commercialization Agreement for BAT2206
Mar 17, 2025 12:30PM Buy this stock as Trump's 'tariff chaos' is priced-in: BofA
Jan 23, 2025 05:41AM CLSA Downgrades Dr. Reddy's Laboratories (DRRD:IN) (RDY) to Underperform (4)
Jan 17, 2025 01:00AM Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) PT Raised to INR1,620 at BofA Securities
Jan 7, 2025 11:53PM Nuvama Upgrades Dr. Reddy\'s Laboratories (DRRD:LN) (RDY) to Buy
Dec 18, 2024 11:13PM Nomura/Instinet Upgrades Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) to Buy
Nov 6, 2024 11:24PM Dr. Reddy\'s Laboratories Ltd. (DRRD:IN) (RDY) PT Raised to INR1,110 at Citi
Nov 5, 2024 10:59PM BofA Securities Reiterates Buy Rating on Dr. Reddy's Laboratories Ltd. (DRRD:IN) (RDY)
Sep 26, 2024 07:20AM UBS Starts Dr. Reddy's Laboratories (DRRD:IN) (RDY) at Sell
Aug 20, 2024 02:53PM Dr. Reddys Labs (RDY), Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
Jul 29, 2024 11:55AM Dr. Reddys Labs (RDY) Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar
Jul 29, 2024 04:01AM Dr. Reddys Labs (RDY) Tops Q2 EPS by 5c
Jul 1, 2024 12:44PM Investec Reiterates Buy Rating on Dr. Reddy\'s Laboratories (DRRD:LN) (RDY)
Jun 28, 2024 12:30AM Citi Reiterates Sell Rating on Dr. Reddy\'s Laboratories (DRRD:IN) (RDY)
Jun 26, 2024 11:27AM Dr. Reddys Labs (RDY) to Acquire Nicotinell and Related Portfolio